Cargando…

Abdominal Ultrasound for the Diagnosis of Tuberculosis Among Human Immunodeficiency Virus-Positive Inpatients With World Health Organization Danger Signs

BACKGROUND: Studies of the value of abdominal ultrasound for diagnosing human immunodeficiency virus (HIV)-associated tuberculosis have major limitations. METHODS: We conducted a prospective study of HIV-positive inpatients with cough and World Health Organization danger signs. The reference standar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griesel, Rulan, Cohen, Karen, Mendelson, Marc, Maartens, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469434/ https://www.ncbi.nlm.nih.gov/pubmed/31011588 http://dx.doi.org/10.1093/ofid/ofz094

Ejemplares similares

Prognostic indicators in the World Health Organization’s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis
por: Griesel, Rulan, et al.
Publicado: (2018)

Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV‐positive individuals
por: Van Hoving, Daniel J, et al.
Publicado: (2019)

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
por: Mendelson, Fiona, et al.
Publicado: (2018)

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
por: Zhao, Ying, et al.
Publicado: (2023)

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV
por: Boyles, Tom H., et al.
Publicado: (2018)

Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected patients
por: Maartens, Gary, et al.
Publicado: (2018)

Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial
por: Griesel, Rulan, et al.
Publicado: (2021)

Diagnostic Outcomes After Chest Radiograph Interpretation in Patients With Suspected Tuberculosis and Negative Sputum Smears in a High-Burden Human Immunodeficiency Virus and Tuberculosis Setting
por: Cudahy, Patrick G. T., et al.
Publicado: (2017)

Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements
por: Wilson, Douglas, et al.
Publicado: (2018)

A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV
por: Boyles, Tom H, et al.
Publicado: (2020)

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
por: Griesel, Rulan, et al.
Publicado: (2023)

Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis
por: Wasserman, Sean, et al.
Publicado: (2016)

Impact of Community-Wide Tuberculosis Active Case Finding and Human Immunodeficiency Virus Testing on Tuberculosis Trends in Malawi
por: Burke, Rachael M, et al.
Publicado: (2023)

CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV
por: Rajpurkar, Pranav, et al.
Publicado: (2020)

Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland
por: Zeeb, Marius, et al.
Publicado: (2023)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014
por: Walaza, Sibongile, et al.
Publicado: (2017)

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
por: De Castro, Nathalie, et al.
Publicado: (2022)

Integrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control Efforts
por: Shenoi, Sheela V, et al.
Publicado: (2017)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis
por: Uzorka, Jonathan W, et al.
Publicado: (2019)

Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis
por: Kay, Alexander, et al.
Publicado: (2022)

Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Blood and Site of Disease Inflammatory Profiles Differ in Patients With Pericardial Tuberculosis and Human Immunodeficiency Virus Type 1
por: Mutavhatsindi, Hygon, et al.
Publicado: (2023)

Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition
por: Luckett, Keith, et al.
Publicado: (2014)

Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals
por: Olsson, Oskar, et al.
Publicado: (2019)

Household Contact Tracing With Intensified Tuberculosis and Human Immunodeficiency Virus Screening in South Africa: A Cluster-Randomized Trial( )
por: Martinson, Neil A, et al.
Publicado: (2021)

Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
por: Humayun, Maheen, et al.
Publicado: (2022)

Phenotypic Profile of Mycobacterium tuberculosis-Specific CD4 T-Cell Responses in People With Advanced Human Immunodeficiency Virus Who Develop Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
por: Moseki, Raymond M, et al.
Publicado: (2022)

Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study
por: Brown, Jennifer A, et al.
Publicado: (2021)

Diabetes Mellitus and Tuberculosis Treatment Outcomes: Interaction Assessment Between Hyperglycemia and Human Immunodeficiency Virus in the State of Georgia, 2015–2020
por: Houck, Kennedy, et al.
Publicado: (2023)

Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus
por: Fujita, Ayako W, et al.
Publicado: (2022)

Lateral Flow Urine Lipoarabinomannan Assay for Diagnosis of Active Tuberculosis in Adults With Human Immunodeficiency Virus Infection: A Prospective Cohort Study
por: Songkhla, Munjit Na, et al.
Publicado: (2019)

Ultrasound Trilaminar Sign of Abdominal Cocoon
por: Indiran, Venkatraman, et al.
Publicado: (2021)

Improving Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) Treatment Monitoring in South Africa: Evaluation of an Advanced TB/HIV Course for Healthcare Workers
por: Galagan, Sean, et al.
Publicado: (2016)

Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria
por: Chang, Charlotte A., et al.
Publicado: (2015)

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial
por: Davis, Angharad G, et al.
Publicado: (2022)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

High Rates of Virological Suppression in a Cohort of Human Immunodeficiency Virus-Positive Adults Receiving Antiretroviral Therapy in Ethiopian Health Centers Irrespective of Concomitant Tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

Effect of Empiric Anti–Mycobacterium tuberculosis Therapy on Survival Among Human Immunodeficiency Virus–Infected Adults Admitted With Sepsis to a Regional Referral Hospital in Uganda
por: Hazard, Riley H, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_85pdlc98h05vvdva0518mkt8i8